Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease.
about
Mucous membrane pemphigoidLinear IgA bullous dermatosis.Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.Chronic ulcerative stomatitis.Desquamative gingivitis: a sign of mucocutaneous disorders--a review.Mucosal disease series. Number III. Mucous membrane pemphigoid.CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis.Mechanisms of blister induction by autoantibodies.Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid.Clinicopathologic features of IgG/IgA pemphigus in comparison with classic (IgG) and IgA pemphigus.Autoantibodies Against Multiple Epitopes in Bp180 and Laminin Gamma-1 in Subepidermal Blistering Skin Disease Associated with Psoriatic Erythroderma.Advanced Diagnostic Techniques in Autoimmune Bullous Diseases.Autoimmunity to deltaNp63alpha in chronic ulcerative stomatitis.Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.Desquamative gingivitis associated with IgG/IgA pemphigoid presents a challenging diagnosis and treatment: a case report.Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.Topical tacrolimus, triamcinolone acetonide, and placebo in oral lichen planus: a pilot randomized controlled trial.Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid.[Mucous membrane pemphigoid].Ocular and oral grading of mucous membrane pemphigoid.Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.Humoral Epitope Spreading in Autoimmune Bullous Diseases.Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases
P2860
Q27691456-960D89AC-769E-42B8-8487-C5B563BA04B8Q33785796-2EE096AA-0292-4E9D-9D26-CDF47C70A717Q34634415-D63BA63D-B520-4852-BA28-7D0329D19241Q34790917-734C9D19-FD8F-44E3-B7D1-12EFC5ACE69FQ35635518-4F3ECB5F-C6F4-40D3-AF5C-0EB10E47E4E2Q36177681-6B4BEC9C-12D6-4128-95DD-ABB0EB4D07F8Q36242319-9BF54192-245B-4019-9CDD-46A7C1B5681AQ36307954-A704D564-6061-4267-8902-C6C0F094BFA7Q39156883-E967FAAF-4FCB-40AE-A29A-CEC2C6726AACQ40323413-349BBBAA-C289-43C8-AA02-86F82D5E0118Q42079726-59261BF9-1FAA-4DEF-A29E-445455E16881Q42239367-59109593-F49A-49A5-8120-E928F62C488EQ42517950-6822E1D3-B537-46EB-9422-564498B5C797Q43789787-1298D98A-7C2C-4983-ACAE-EF13AF65AFA9Q45283556-834E54B8-C986-4785-B589-58D09872DF16Q47373873-BD30B801-74C3-4758-BAE4-43783FF74DF4Q48256118-F2D7982B-BD24-423F-8D34-77F0E6099269Q48268268-4021C805-2FA6-4631-B86D-572C3355FA69Q48279461-8DB9CF5F-A1DD-4DA2-9837-CE916B389C36Q49833864-37450B87-1E46-4B1F-8169-4FBEF861EC3AQ53091231-F0B1497E-6C5B-4DC2-A229-E35821D88FF9Q55154455-41DDFCF3-753B-496F-B917-B1C230BD65DBQ55262188-7F04F273-B0F3-4C1E-B8D9-57FE737EAFBCQ58727116-9CA64FD7-E1C2-488B-9811-BBA839EBD50E
P2860
Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Mucous membrane pemphigoid: a ...... severe and persistent disease.
@en
Mucous membrane pemphigoid: a ...... severe and persistent disease.
@nl
type
label
Mucous membrane pemphigoid: a ...... severe and persistent disease.
@en
Mucous membrane pemphigoid: a ...... severe and persistent disease.
@nl
prefLabel
Mucous membrane pemphigoid: a ...... severe and persistent disease.
@en
Mucous membrane pemphigoid: a ...... severe and persistent disease.
@nl
P2093
P2860
P50
P1476
Mucous membrane pemphigoid: a ...... severe and persistent disease
@en
P2093
P2860
P304
P356
10.1046/J.1365-2133.1998.02168.X
P407
P577
1998-04-01T00:00:00Z